+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial



Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial



Lancet 359(9300): 23-29



Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. We compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Primary outcome was number of days with platelet count greater than 50 x 10(9)/L within the first 21 days. We did a randomised multicentre trial based on a 232 design. 122 adults with severe AITP (platelet count < or =20 x 10(9)/L) were randomly assigned to receive either intravenous immunoglobulin or high-dose methylprednisolone on days 1-3 (randomisation A), and then to receive either oral prednisone or placebo (randomisation B) on days 4-21. Analysis was by intention to treat. Six patients were excluded from the analysis. The number of days on which platelet counts were above 50 x 10(9)/L was 18 in 56 patients receiving intravenous immunoglobulin and 14 in 60 receiving high-dose methylprednisolone (p=0.02). Percentage of patients who had platelet counts over 50 x 10(9)/L on days 2 and 5 was 7% and 79%, respectively, in the intravenous immunoglobulin group compared with 2% and 60%, respectively, in the high-dose methylprednisolone group (p=0.04). During the second treatment period, prednisone was more effective than placebo for all short-term endpoints. Patients who received intravenous immunoglobulin and prednisone had platelet count greater than 50 x 10(9)/L for 18.5 days (p=0.005), and those treated with high-dose methylprednisolone and prednisone had this count for 17.5 days. Intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated.

(PDF emailed within 0-6 h: $19.90)

Accession: 010877025

Download citation: RISBibTeXText

PMID: 11809183

DOI: 10.1016/S0140-6736(02)07275-6


Related references

High-dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids. American Journal Of Hematology. 48(4): 282-284, 1995

Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (North American Edition) 344(8924): 703-707, 1994

Oral high-dose methylprednisolone and intravenous immunoglobulin treatments in adult chronic idiopathic thrombocytopenic purpura. American Journal Of Hematology. 56(3): 192,., 1997

Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. Journal of Pediatric Hematology/Oncology 24(7): 540-544, 2002

The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. British Journal of Haematology 105(4): 1130-1132, June 2, 1999

High dose intravenous methylprednisolone is effective in adult acute autoimmune thrombocytopenic purpura. British Journal of Haematology 93(SUPPL 2): 184, 1996

Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Puerto Rico Health Sciences Journal 19(1): 15-18, 2000

Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. British Journal of Haematology 107(4): 716-719, 1999

Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. British Journal of Haematology 107(4): 716-719, 1999

Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults. Nederlands Tijdschrift Voor Geneeskunde 143(41): 2053-2057, 1999

Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood 82(5): 1415-1421, 1993

High dose intravenous immunoglobulin g for chronic idiopathic thrombocytopenic purpura in adults. International Society Of Blood Transfusion Abstracts Of The Congress Of The International Society Of Blood Transfusion, No 18 Symposium; Munich, West Germany, July 22-27, 240p S Karger: Basel, Switzerland; New York, N Y , Usa Illus Paper 191, 1984

Persistent remission of adult chronic autoimmune thrombocytopenic purpura after treatment with high-dose intravenous immunoglobulin. American Journal of Hematology 25(3): 271-275, 1987

A randomized trial of intravenous gamma globulin high dose methylprednisolone or no therapy as initial management of idiopathic thrombocytopenic purpura itp. Pediatric Research 31(4 PART 2): 146A, 1992

Treatment of chronic idiopathic thrombocytopenic purpura in adults with high-dose intravenous immunoglobulin. Ugeskrift for Laeger 145(25): 1934-1937, 1983